Company / Operating Income
Tandem Diabetes Care Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$187.3M
FY2025
5-year range
-$233.2M / -$8.0M
FY2021-FY2025
Trend
-88.9%
vs FY2024
Sector context
#138 of 156
Health Care
What the data says
Tandem Diabetes Care's operating income of -$187M is lower than 88% of companies in the Health Care sector (FY2025). Operating Income has fluctuated over the past 10 years, ranging from -$233M in FY2023 to -$8M in FY2022.
Based on SEC 10-K filings.
-$187M in FY2025.
Improved from -$233M to -$187M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 156This company -$187.3M Sector average $733.1M
▼
-125.5% below sector average
Key checks
Key Insights
- In FY2025, operating income decreased 88.9% year-over-year.
- Ranks #138 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2022.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$187.3M | -88.9% |
| FY2024 | -$99.1M | +57.5% |
| FY2023 | -$233.2M | -2831.1% |
| FY2022 | -$8.0M | +52.4% |
| FY2021 | -$16.7M | +62.5% |
| FY2020 | -$44.6M | +29.1% |
| FY2019 | -$62.9M | +19.4% |
| FY2018 | -$78.1M | -13.1% |
| FY2017 | -$69.0M | +11.6% |
| FY2016 | -$78.1M | -13.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026